RNA viruses pose significant challenges to public health due to their high mutation rates and diverse mechanisms of infection which allow them to rapidly adapt to new hosts and evade therapeutic ...
BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...